Dr. Cameron Clokie a Leading Surgeon in the Oral and Maxillofacial Field in the City of Toronto, Canada

Health

Cameron Clokie is a man who has many titles to his name; he is a maxillofacial surgeon, serial entrepreneur, teacher, and scientist. Clokie serves as the Chief Executive Officer of Induce Biologics Inc. Induce Biologics is a regenerative medicine firm that specializes on musculoskeletal reconstruction innovative solution and is based in Toronto, Canada.

Clokie Cameron has over 30 years worth of experience and has been involved in academic dentistry and clinic practice. Clokie has served as the as a professor and head of Oral and Maxillofacial surgery at the University of Toronto a position he served until his time of retirement in 2017. Learn more about Cameron Clokie:

Oral and Maxillofacial surgery entails the treatment of defects and injuries including many diseases that affects the jaws, face, neck, head and soft and hard tissues of the mouth.

Dr. Cameron Clokie has a rich academic background. He attended McGill University popularly known as a public research campus which is located in Montreal, Quebec province, Canada where he pursued his Doctor of Dental Surgery Degree and a Ph.D. in bone regeneration and interfaced development. Learn more about Cameron Clokie: http://inducebiologics.com/index.php?option=com_content&view=article&id=46&Itemid=18 and https://www.ratemds.com/doctor-ratings/1215496/Dr-Cameron-Clokie-Toronto-ON.html

Clokie due to his increased expertise and innovative strategies in jaw bone regeneration has turned out to be one of the most sought-after Oral and Maxillofacial Surgeon and lecturer.

Clokie has been invited to several top-rated universities to offer lectures on various topics regarding bone regeneration, Oral and Maxillofacial Surgery, future of Dentistry and university-related technology transfer. Read more: Cameron Clokie Believes Technology is Changing Dentistry For The Better

Clokie has created a name for himself as the industry leader in Oral Maxillofacial Surgery. Clokie began his research group at McGill University in 1993 and later in 1998 moved it to the University of Toronto where he transferred as a professor. Clokie founded the research group with the aim of conducting extensive researches on bone regenerative technologies.

Clokie research is focused on developing bio-implants that would ultimately replace the use of autogenous bone grafts methods which is a painful and challenging process of bone replacement.

Clokie as an entrepreneur maintains a clinical practice in Toronto, Ontario, Canada that deals with bone regeneration and facial reconstruction. It is no doubt that Clokie has accomplished a lot in his long career as an Oral and Maxillofacial Surgeon. Clokie has over 25 patents to his name and has authored many publications.

A river of information – Oncotarget

Health, Health Care

With new challenges being presented every day in the field of oncology it is incredibly important for the entire industry to be on their toes for whatever they may face. As a part of this, new research is in constant circulation and many platforms offer a way for members of the medical field to access this new information. However, one platform, in particular, stands out: Oncotarget.Oncotarget began publishing in 2010 and continues today. They have a dedicated focus on providing scientific research publicly, promoting cooperation and collaborations among differing specialties, and to quickly disperse new discoveries so that they may be used to combat diseases.

Oncotarget publishes journal weekly which provides a plethora of information for readers through peer-reviewed articles. According to the SJR, Oncotarget had over 6,000 documents published alone in 2016, more than any other journal in the same field.Beyond impressive publication numbers, Oncotarget has an impressive team of editors and contributors that drives Oncotangents continuously flourishing success. Chief Editors Dr. Andrei Gudkov and Dr. Mikhail Blagosklonny are both incredibly accomplished in their line of work.

With Dr. Gudkov being the co-founder of Cleveland BioLabs and Dr. Mikhail having over 250 peer-reviewed journals to his name. Beyond this, Oncotarget has had four members of their team win the Life Sciences Breakthrough Prize since 2013.Although they originated as a journal specializing in oncology, Oncotarget has expanded to other horizons with the acceptance of other types of medical publishings dealing with endocrinology, cell biology, neuroscience and many more areas. Oncotarget continues to produce weekly content and stands out as a cut above the rest in the world of medical journals.

Get to know about Rick Shinto and Penelope Kokkinides the faces behind InnovaCare Health

Health, Health Care

InnovaCare Health is the number one provider of controlled health care services in North America. Medicare Advantage, Provider Networks, and Medicaid Programs are the primary avenues of care that they use to provide access to excellent healthcare services by creating programs that are cost effective, sustainable, and fully integrated with modern technology.

The leadership at INNOVACARE HEALTH

Rick Shinto

Dr. Rick is the present president and CEO of InnovaCare Inc. He additionally filled in as the president and CEO of Aveta Inc from 2008 to 2012 when the organization was sold. Before that, he was in the management team.Rick utilized the tremendous experience to make InnovaCare Health the fruitful entity it is today. As the CEO, he began many activities that have seen numerous needy patients get quality health services.Under his authority, more than two hundred thousand patients have joined its membership program that has more than 7500 workers. As indicated by Rick, the health care does treat their patients, as well as instruct them to beware.Furthermore, they offer help to their friends and family when the patients are recuperating.

Honors

The actions above earned Rick Shinto Access to Caring Award. The honor was given to him at Wester University of health sciences.

Penelope Kokkinides

She is the current chief administrative officer with the organization since 2015. Before that, she had served as the chief operating officer at InnovaCare and Aveta. She has more than two decades experience in health care services specializing in programs by the government and the managed care industry. She has vast skills and knowledge in managing health care operations and processes and developing clinical programs with the aim of improving organizational infrastructure and efficiencies.

Education

Penelope Kokkinides attended Binghamton University where she graduated with a bachelor’s degree in biological sciences and classical languages. She also graduated with a master’s degree from the University of New York and posts masters advanced degree in alcohol and substance abuse from Columbia University.Other leaders in the institution are:

  • Douglas Malton – Chief Financial Officer
  • Jonathan A. Meyers – Chief Actuary Officer
  • Christopher Joyce – General Counsel
  • Michael J. Sortino – Chief Accounting Officer
  • S Bhasker – Chief Information Officer

In conclusion, InnovaCare Health is changing the health care system to meet the difficulties of the current complex healthcare environment while upholding the excellent health values.